Study: PBMs lower most drug costs for most people, encourage...
Skyrocketing costs for prescription drugs has put scrutiny on the role pharmacy benefit managers, or PBMs, play in negotiating pharmaceutical prices with manufacturers on behalf of insurers who provide health policies for nearly 300 million Americans. Drawing heat from the Trump Administration, Congress and state lawmakers around the nation is the opaque PBM practice of securing rebates - or clawbacks - from drug-makers and imposing rules that forbid pharmacists from discussing prescription drug prices with customers.
Start the conversation, or Read more at Sedalia Democrat.
Add your comments below
|Public housing residents in Louisville brace fo...||1 hr||American||1|
|What's available for seniors?||2 hr||jerry smallwood||2|
|Attorney general: Oklahoma board went too far w...||4 hr||gonetoofar||1|
|Q&A with Beth Harwell, candidate for governor||6 hr||No Doubt||1|
|Human Sexuality (Jun '16)||8 hr||johnfire69||25|
|Harbor-UCLA Medical Center cited for safety vio... (Oct '11)||10 hr||Raj Chanani||285|
|It's bedbug season, Halton Region - here's what...||12 hr||Rest||1|
Find what you want!
Search Health Forum Now
Copyright © 2018 Topix LLC